RESLIZUMAB vs REZAFUNGIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RESLIZUMAB vs REZAFUNGIN: Safety Overview
| Metric | RESLIZUMAB | REZAFUNGIN |
|---|---|---|
| Total FAERS Reports | 621 | 108 |
| Deaths Reported | 15 | 12 |
| Death Rate | 2.4% | 11.1% |
| Hospitalizations | 121 | 20 |
| Average Patient Age | 55.9 yrs | 53.8 yrs |
| % Female Patients | 63.2% | 54.3% |
| FDA Approval Date | N/A | Mar 22, 2023 |
| Manufacturer | Teva Respiratory, LLC | Melinta Therapeutics, LLC |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |